PhD, Cancer Immunotherapy-Applied Medicine
University of Navarra, Pamplona, Spain
MSc, Translational Oncology & Cancer Biology
BSc, Biological Sciences
BA, Linguistics
Emory University, Atlanta, GA
Ashwathi Puravankara Menon provides senior leadership in medical affairs at RTI-HS. Dr. Menon is a former Marie Curie Fellow and a seasoned expert in cancer immunotherapy and translational oncology/haematology with more than 8 years of research experience. She has lead drug development pipelines for RNA therapeutics (Aptamers), CD3 Bispecifics, T-cell–based therapies (CARs, TCR T-cells, and adoptive T-cell therapies), and personalised vaccines for a wide variety of cancers. Dr. Menon previously worked in the pharmaceutical industry as a global medical advisor, developing medical education portfolios for engaging healthcare professionals, key opinion leaders, and business partner networks. She has coordinated international product launches and conferences and provided support for regulatory submissions. She has also worked in the medical communications sector, developing medical educational materials for all types of audiences and is an accomplished medical writer, science podcaster, and illustrator. She also has experience in the fields of psychiatry/neuroscience (schizophrenia), cardiovascular, and respiratory diseases.